Skip to content

OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study

MDS | Myelodysplastic Syndromes | Myelodysplastic/Myeloproliferative Neoplasms | RARS-T

A prospective, single center, single arm phase 2 cohort feasibility study of the OURA ring in adult MDS patients. Patients with MDS will wear the OURA ring and upload biometrics weekly. Quality of life measures will be clinically evaluated and correlated with biometrics. We hypothesize that it will be feasible for MDS patients to wear the OURA ring 70% of the time for 3 months.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

1. Provision of signed and dated informed consent form
2. Stated willingness to comply with all study procedures and availability for the duration of the study
3. Male or female, aged 18 or older
4. Able to read, write and speak English or French (non-English or French speaking patients may participate if appropriate translation is used)
5. Diagnosed with Myelodysplastic Syndrome using WHO 2022 criteria (12) all risk groups
6. Ability to wear the OURA ring and operate the associated smart-phone app, and willing to adhere to the study regimen

Exclusion Criteria:

1. Performance status ECOG \> 3.
2. Cognitive or physical impairment preventing the usage or utilization of the OURA ring and smart phone.

Lieu de l'étude

Sunnybrook Health Sciences Research Centre
Sunnybrook Health Sciences Research Centre
Toronto, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Rena Buckstein

[email protected]
416-480-5000
Backup Contact

Geetha Yogendran

[email protected]
416-480-5000
Étude parrainée par
Sunnybrook Health Sciences Centre
Participants recherchés
Plus d'informations
ID de l'étude: NCT06270771